Premium
LONG‐TERM FOLLOW‐UP AND PREDICTORS OF POOR OUTCOME IN PATIENTS WITH FOLLICULAR LYMPHOMA UNDERGOING FRONT‐LINE TREATMENT WITH CHEMOIMMUNOTERAPY: A SINGLE CENTER EXPERIENCE.
Author(s) -
Donato E.,
Marriaga L.,
Legarda M.,
Rubio L.,
Sayas M.J.,
Fernández M.,
Ribas P.,
Juan M.L.,
Marco J.,
Fernández M.J.,
Gómez E.,
Tolosa A.,
Hueso J.A.,
Cejalvo M.J.,
Ivars D.,
De la Rubia J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_127
Subject(s) - medicine , chemoimmunotherapy , rituximab , univariate analysis , progression free survival , surgery , single center , proportional hazards model , international prognostic index , retrospective cohort study , regimen , lymphoma , chemotherapy , multivariate analysis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom